First Page | Meta Content | |
---|---|---|
Document Date: 2015-02-06 19:52:05Open Document File Size: 732,56 KBShare Result on FacebookCitySt. Joseph / Ames / /CompanyBoehringer Ingelheim / Boehringer Ingelheim Ingelheim / Boehringer Ingelheim Vetmedica Inc. / Ingelheim Vetmedica Inc. / Animal Health / /ContinentEurope / /CountryGermany / Netherlands / United States / United Kingdom / /EventFDA Phase / /FacilityUniversity of Edinburgh / /HolidaySt. Joseph / /IndustryTermImportant products / food-producing ani solutions / nutritious food / agricultural products / novative technologies / food / vative solutions / pharmaceutical research / vac ble networks / health products / therapeutic solutions / emphasis products / diag search / complemented products / /MedicalConditionsingle shot spread diseases / epidemic / strain / Multi Acronym Disease / Mysterious Swine Disease / PRRS virus / acute disease / infectious animal search / animal diseases / spe cific diseases / M.hyo-induced diseases / ileitis / disease / infectious animal diseases / attenuated PRRS / Respiratory Syndrome / secondary infections / M.hyoinduced diseases / fever / early infection / optimum diseases / diseases / infection / cough / infectious agent spreads / prrs / Syndrome / /MedicalTreatmentantibiotics / vaccination / /OrganizationEuropean Veterinary Disease Management Center / University of Edinburgh / /PersonVolker Ohlinger / Hubert Hummelt / Jeremy Kroll / Roof / Michael Roof Jeremy Kroll Knut / Sharlene Miller / /PositionBoehringer Chairman / veterinarian / scientist / Introduction Introduction Albrecht Kissel Head of Business Development The / Director Based / Head of R&D / leader / Mission Ambition Joachim Hasenmaier Managing Director / scientist at ingelvac mycoflex® has been developed / Head / /ProductPRRS vaccine / United States / /ProvinceOrStateMinnesota / Missouri / Iowa / /Regionnorthern Germany / East Asia / /SocialTag |